Fibroblast Biology in Skin Aging and Rejuvenation
Dermatologic Therapy · 2026-01 · 2026 (1)
DOI: 10.1155/dth/9742005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatologic Therapy, online erschienen am 23.07.2026. Verfasst von Maurizio Cavallini. Die Arbeit nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Fibroblasts are the principal mesenchymal cells of the dermis and comprise heterogeneous papillary, reticular, and dermo–hypodermal populations with distinct roles in extracellular matrix (ECM) production, tissue repair, and skin aging. Oxidative stress, ultraviolet exposure, and collagen fragmentation impair fibroblast–ECM interactions and mechanotransduction, contributing to reduced Type I and III collagen synthesis, increased matrix metalloproteinase activity, dermal thinning, laxity, and loss of elasticity. This narrative review summarizes current evidence on dermal fibroblast heterogeneity, senescence, mechanobiology, and their relevance to aesthetic and regenerative dermatology. Injectable biomaterials, energy‐based devices, platelet‐rich plasma, exosome‐rich formulations, and stem cell–conditioned media may influence fibroblast activity through mechanical, thermal, or paracrine mechanisms. However, the level of evidence varies substantially across modalities, ranging from biopsy‐controlled human studies and randomized trials for selected interventions to predominantly preclinical or small exploratory studies for emerging approaches. Fibroblast compartmentalization provides a rationale for depth‐oriented treatment strategies. Superficial interventions, such as non–cross‐linked hyaluronic acid and fractional lasers, may preferentially affect the papillary dermis, whereas deeper modalities, including calcium hydroxylapatite, poly‐L‐lactic acid, radiofrequency, and focused ultrasound, may engage reticular and deeper dermal compartments. Emerging layered biostimulation protocols aim to combine modalities acting at different tissue depths, but this approach remains supported mainly by mechanistic reasoning and uncontrolled clinical experience rather than direct comparative trials. Future directions include senescence‐targeted therapies, metabolic and mitochondrial support strategies, and biomaterials designed to combine structural support with controlled biochemical signaling. These approaches remain largely preclinical or early stage in aesthetic dermatology. Overall, fibroblast biology provides a mechanistic framework for interpreting current and emerging rejuvenation strategies, but standardized clinical protocols will require stronger human evidence, harmonized outcome measures, and long‐term safety data.
Zitieren
APA
Cavallini, M. (2026). Fibroblast Biology in Skin Aging and Rejuvenation. Dermatologic Therapy, 2026(1). https://doi.org/10.1155/dth/9742005
Vancouver
Cavallini M. Fibroblast Biology in Skin Aging and Rejuvenation. Dermatologic Therapy. 2026;2026(1). doi:10.1155/dth/9742005
BibTeX
@article{Cavallini2026,
author = {Cavallini, Maurizio},
title = {Fibroblast Biology in Skin Aging and Rejuvenation},
journal = {Dermatologic Therapy},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/dth/9742005}
}
EUVIMED